© 2002 by Oxford University Press
Journal of the National Cancer Institute, Vol. 94, No. 4, 245-247,
February 20, 2002
© 2002 Oxford University Press
NEWS |
Developing Countries Put Cervical Cancer Tests to the Test
Since the Pap test debuted in the 1960s, countries in the developed world have seen their cervical cancer mortality rates decline. In the United States, cervical cancer rates have dropped about 80% in the last 40 years. But because poorer nations cannot afford nationwide screening programs, their rates of cervical cancer have continued to rise.
"Cervical cancer is one of those health issues between the developed and developing world where there are clear inequities in care," said Thomas C. Wright, M.D., professor of pathology at Columbia University in New York.
| |||||||||||
Simpler and less costly screening tests exist, and researchers are trying to predict how well these tests might perform in different resource settings. But the right test is only one component of an effective screening program.
More important, how do you ensure that all women who test positive for abnormalities will return for treatment? And
Alternative Tests
HPV Testing
Computer Models
New Challenges
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
E. J. Suba, S. K. Murphy, A. D. Donnelly, L. M. Furia, M. L. D. Huynh, and S. S. Raab Systems Analysis of Real-World Obstacles to Successful Cervical Cancer Prevention in Developing Countries Am J Public Health, March 1, 2006; 96(3): 480 - 487. [Abstract] [Full Text] [PDF] |
||||
